12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Oncolytics, Pfizer deal

PFE obtained worldwide development and commercialization rights for animals to ONC's reovirus, which infects and kills cancer...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >